The authors wish to make a correction to the published paper \[[@B1-nutrients-12-01968]\] in Section 1 to make the sentence more understandable. The edited sentence is the following: "It is noteworthy that an enzyme semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1), which is responsible for deamination of the primary amines such as methylamine and converts them into cytotoxic aldehydes (e.g., formaldehyde), ammonia, and hydrogen peroxide, is found to be associated with obesity and related diseases."

In Section 3, [Table 1](#nutrients-12-01968-t001){ref-type="table"}, the edition is needed. In Caffeine row (IC~50~), misspelled "nM" is corrected into "mM". The edited version of the [Table 1](#nutrients-12-01968-t001){ref-type="table"} is given below:

In Section 4, an amendment is needed to solve the inconsistency in the sentence. The corrected version of the sentence is the following: "Olivieri and Tipton have revealed the inhibitory concentration (IC) of caffeine intake---0.1--10 mM (IC~50~ = 0.8 ± 0.3 mM). As stated in the studies, the recommended daily dose of caffeine (400 mg) for adults is consistent with 1-4 cups of regular coffee and is not associated with unfavorable effects on health."

Here is the specific response of the authors to the concerns that were raised in the comment \[[@B2-nutrients-12-01968]\]. Although Olivieri et al. have demonstrated that caffeine exerts the inhibition of bovine serum SSAO with a concentration of IC~50~ of 0.8 ± 0.3 mM (in particular, in the concentration range of 0.1--10 mM inhibits SSAO activity) \[[@B3-nutrients-12-01968]\] that exceeds the concentration range of caffeine in serum of humans, an animal study conducted by Che et al. revealed that caffeine might be a promising inhibitor of SSAO even with low (nonlethal) concentrations \[[@B4-nutrients-12-01968]\]. However, no human studies have been carried out in terms of using caffeine as an inhibitor of enzyme SSAO that may show the different range of caffeine's inhibitory concentration.

Although Westerterp-Plantenga manifested weight loss and weight maintenance when caffeine together with green tea extract was administered \[[@B5-nutrients-12-01968]\], in our article, we present an evidence-based discussion of the weight-gain diminishing capacity of caffeine \[[@B6-nutrients-12-01968],[@B7-nutrients-12-01968],[@B8-nutrients-12-01968],[@B9-nutrients-12-01968],[@B10-nutrients-12-01968]\]. In addition, the current manuscript does not focus on the state of the body (whether the body is in resting or active state) during caffeine intake and its action. The main point of our article is to provide data about weight gain attenuation by inhibiting SSAO, and it discusses the convenience of some potential inhibitor substances. Moreover, caffeine is less risky and the only popular natural compound with the potential capacity to inhibit the enzyme SSAO. While caffeine is already famous with its antilipolytic effects \[[@B6-nutrients-12-01968],[@B7-nutrients-12-01968],[@B8-nutrients-12-01968],[@B9-nutrients-12-01968],[@B10-nutrients-12-01968]\], evincing another possible beneficial property \[[@B3-nutrients-12-01968],[@B4-nutrients-12-01968]\] makes sense. Thus, the assumption of the dual beneficial role of caffeine in this article remains rational. Consequently, we believe human studies need to be carried out on SSAO inhibition by caffeine. The authors appreciate the opportunity to respond to the comment by Willson \[[@B2-nutrients-12-01968]\] and hope the information given is satisfactory and clear.

The authors apologize to the readers for any inconvenience caused by this amendment. This amendment does not affect the results or conclusion of the manuscript in any way. The original manuscript will remain online on the article webpage with a reference to this correction.

The authors declare no conflict of interest.
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###### 

Description of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1) inhibitors according to chemical and pharmacological properties.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Names of VAP-1/SSAO Inhibitors   Chemical Structure/Formula          Molecular Weight/Molar Weight   Solubility        Pharmacokinetic Profile   IC~50~          Efficacy/Anti-Obesity Property   Toxicity                                                                                                                                                                                                                                                                                                          Source     
  -------------------------------- ----------------------------------- ------------------------------- ----------------- ------------------------- --------------- -------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- -------------------------
  PXS-4728A/BI1467335              ![](nutrients-12-01968-i001.jpg)\   316.8014 kDa                    DMSO and H~2~O\   6 mg·kg^−1^\              3 mg·kg^−1^\    5 nM                             Potent and orally available inhibitor of VAP-1, showing \>500-fold selectivity for VAP-1/SSAO over all the related human amine oxidases. Diminishes lung inflammation. It is in clinical trials for the treatment of cardio-metabolic diseases. It shows significant reduction of body weight gain in rabbits.\   No/Low     Wang et al.\
                                   C~15~H~22~ClFN~2~O~2~                                               \>10 mg/mL        10 mg·kg^−1^              5 mg·kg^−1^                                      Axon Medchem, Groningen, Netherlands                                                                                                                                                                                                                                                                                         Schilter et al.\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Kim et al.

  PXS-4681A                        ![](nutrients-12-01968-i002.jpg)\   342.84 kDa                      H~2~O\            20 mg·kg^−1^\             10 mg·kg^−1^\   \<10 nM                          Potent and highly selective irreversible inhibitor of SSAO/VAP-1 that exhibits anti-inflammatory effects in vivo. It is a derivative of Mofegiline. PXS-4681A was used to inhibit LPS induced brain inflammation.\                                                                                                No/Low     Becchi et al.\
                                   C~17~H~24~ClFN~2~O~2~                                               2 mg/mL           2 mg·kg^−1^               2 mg·kg^−1^                                      Sigma-Aldrich, St. Louis, USA                                                                                                                                                                                                                                                                                                Foot et al.

  Semicarbazide                    ![](nutrients-12-01968-i003.jpg)\   75.07 g/mol                     N/A               N/A                       N/A             N/A                              An irreversible and probably suicide SSAO inhibitor. It limits weight gain and fat accumulation.\                                                                                                                                                                                                                 Yes/High   Mercader et al.
                                   CH~5~N~3~O                                                                                                                                                       Sigma-Aldrich, Saint Quentin Fallavier, France                                                                                                                                                                                                                                                                               

  LJP-1586                         ![](nutrients-12-01968-i004.jpg)\   231.69 kDa                      DMSO              10 mg/kg                  N/A             4--43 nM                         Potent, selective, and orally active inhibitor of SSAO activity, inhibiting vascular adhesion protein 1 (VAP-1) activity and decreasing the density of macrophages in inflamed atherosclerotic plaques in mice LJP.\                                                                                              Yes        O'Rourke et al.
                                   C~11~H~15~ClFNO                                                                                                                                                  Glixx Laboratories Inc., Hopkinton, USA                                                                                                                                                                                                                                                                                      

  Caffeine                         ![](nutrients-12-01968-i005.jpg)\   194.19 g/mol                    H~2~O             N/A                       N/A             0.8 ± 0.3 mM                     Efficiency of caffeine on adipose and aorta is especially high. It can play an important role in treating diseases associated with SSAO activities. Independently of SSAO inhibition, it is found to be effective in losing weight.National Institute for Drug Control, Beijing, China                            No/Low     Che et al. Zheng et al.
                                   C~8~H~10~N~4~O~2~                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Simvastatin                      ![](nutrients-12-01968-i006.jpg)\   418.6 g/mol                     DMSO and H~2~O    N/A                       20 mg·kg^−1^    N/A                              Simvastatin blocks SSAO/VAP-1 release, among other known actions, therefore preventing this cascade of events.Sigma-Aldrich, Madrid, Spain                                                                                                                                                                        Yes        Sun et al.
                                   C~25~H~38~O~5~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Phenylhydrazine                  ![](nutrients-12-01968-i007.jpg)\   108.14 g/mol                    H~2~O             N/A                       N/A             30 nM                            Irreversible SSAO inhibitor.Shows diminishing body weight gain.Sigma-Aldrich, Poole, UK                                                                                                                                                                                                                           Yes/High   Carpene et al.\
                                   C~6~H~8~N~2~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Lizcano et al.

  Phenelzine                       ![](nutrients-12-01968-i008.jpg)\   136.19 g/mol                    H~2~O             30 mg·kg^−1^              88.9 µmol/kg    N/A                              Potent inhibitor of SSAO.Shows attenuation of adiposity.Sigma-Aldrich, Saint Quentin Fallavier, France                                                                                                                                                                                                            Yes        Carpene et al.
                                   C~8~H~12~N~2~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
